Correlation Between Sangamo Therapeutics and ArriVent BioPharma,
Can any of the company-specific risk be diversified away by investing in both Sangamo Therapeutics and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sangamo Therapeutics and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sangamo Therapeutics and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Sangamo Therapeutics and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sangamo Therapeutics with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sangamo Therapeutics and ArriVent BioPharma,.
Diversification Opportunities for Sangamo Therapeutics and ArriVent BioPharma,
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Sangamo and ArriVent is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Sangamo Therapeutics and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Sangamo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sangamo Therapeutics are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Sangamo Therapeutics i.e., Sangamo Therapeutics and ArriVent BioPharma, go up and down completely randomly.
Pair Corralation between Sangamo Therapeutics and ArriVent BioPharma,
Given the investment horizon of 90 days Sangamo Therapeutics is expected to generate 1.4 times more return on investment than ArriVent BioPharma,. However, Sangamo Therapeutics is 1.4 times more volatile than ArriVent BioPharma, Common. It trades about -0.14 of its potential returns per unit of risk. ArriVent BioPharma, Common is currently generating about -0.22 per unit of risk. If you would invest 113.00 in Sangamo Therapeutics on November 28, 2024 and sell it today you would lose (15.00) from holding Sangamo Therapeutics or give up 13.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sangamo Therapeutics vs. ArriVent BioPharma, Common
Performance |
| Timeline |
| Sangamo Therapeutics |
| ArriVent BioPharma, |
Sangamo Therapeutics and ArriVent BioPharma, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sangamo Therapeutics and ArriVent BioPharma,
The main advantage of trading using opposite Sangamo Therapeutics and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sangamo Therapeutics position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.| Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
| ArriVent BioPharma, vs. Yuexiu Transport Infrastructure | ArriVent BioPharma, vs. Rambler Metals and | ArriVent BioPharma, vs. Pearson PLC ADR | ArriVent BioPharma, vs. Afya |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Directory Find actively traded commodities issued by global exchanges |